🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Paul Tudor Jones’s AMGN Holdings & Trades

First Buy
Q2 2013
Duration Held
45 Quarters
Largest Add
Q1 2024
+164,400 Shares
Current Position
825 Shares
$347,746 Value

Paul Tudor Jones's AMGN Position Overview

Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 825 shares of Amgen Inc. (AMGN) worth $347,746, representing 0.00% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 45 quarters.

Based on 13F filings since 2013, Paul Tudor Jones has maintained a long-term strategic position in AMGN, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2024, adding 164,400 shares. Largest reduction occurred in Q2 2024, reducing 164,400 shares.

Analysis based on 13F filings available since 2013 Q2

Paul Tudor Jones's Amgen (AMGN) Holding Value Over Time

Track share changes against reported price movement

Quarterly Amgen (AMGN) Trades by Paul Tudor Jones

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +825 New Buy 825 $421.51
Q4 2025 -119,834 Sold Out 0 $0.00
Q3 2025 +62,743 Add 109.90% 119,834 $282.20
Q2 2025 +6,736 Add 13.38% 57,091 $279.21
Q1 2025 -8,814 Reduce 14.90% 50,355 $311.55
Q4 2024 +59,169 New Buy 59,169 $260.64
Q2 2024 -164,400 Sold Out 0 $0.00
Q1 2024 +164,400 New Buy 164,400 $284.32
Q3 2023 -18,616 Sold Out 0 $0.00
Q2 2023 -78,777 Reduce 80.89% 18,616 $222.02
Q1 2023 +97,393 New Buy 97,393 $0.24
Q3 2022 -11,779 Sold Out 0 $0.00
Q2 2022 +7,160 Add 155.01% 11,779 $243.31
Q1 2022 +4,619 New Buy 4,619 $241.83
Q4 2021 -4,491 Sold Out 0 $0.00
Q3 2021 -1,371 Reduce 23.39% 4,491 $212.65
Q2 2021 +5,862 New Buy 5,862 $243.77
Q3 2020 -7,423 Sold Out 0 $0.00
Q2 2020 -3,364 Reduce 31.19% 7,423 $235.89
Q1 2020 -507 Reduce 4.49% 10,787 $202.74
Q4 2019 +11,294 New Buy 11,294 $241.10
Q3 2019 -2,279 Sold Out 0 $0.00
Q2 2019 -36,014 Reduce 94.05% 2,279 $184.29
Q1 2019 +38,293 New Buy 38,293 $189.98
Q3 2018 -16,497 Sold Out 0 $0.00
Q2 2018 -8,757 Reduce 34.68% 16,497 $184.58
Q1 2018 +15,538 Add 159.92% 25,254 $170.47
Q4 2017 +9,716 New Buy 9,716 $173.94
Q2 2017 -7,832 Sold Out 0 $0.00
Q1 2017 +4,132 Add 111.68% 7,832 $164.07
Q4 2016 -17,633 Reduce 82.66% 3,700 $146.22
Q3 2016 +15,664 Add 276.31% 21,333 $166.83
Q2 2016 +369 Add 6.96% 5,669 $152.23
Q1 2016 -2,729 Reduce 33.99% 5,300 $150.00
Q4 2015 +1,229 Add 18.07% 8,029 $162.29
Q3 2015 -1,175 Reduce 14.73% 6,800 $138.38
Q2 2015 -1,890 Reduce 19.16% 7,975 $153.48
Q1 2015 +5,265 Add 114.46% 9,865 $159.86
Q4 2014 +1,300 Add 39.39% 4,600 $159.35
Q3 2014 -5,713 Reduce 63.39% 3,300 $140.61
Q2 2014 +5,028 Add 126.17% 9,013 $118.38
Q1 2014 -3,712 Reduce 48.23% 3,985 $123.46
Q4 2013 +7,697 New Buy 7,697 $114.07
Q3 2013 -6,300 Sold Out 0 $0.00
Q2 2013 +6,300 Add 0.00% 6,300 $98.73

Paul Tudor Jones's Amgen Investment FAQs

Paul Tudor Jones first purchased Amgen Inc. (AMGN) in Q2 2013, acquiring 6,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Paul Tudor Jones has held Amgen Inc. (AMGN) for 45 quarters since Q2 2013.

Paul Tudor Jones's largest addition to Amgen Inc. (AMGN) was in Q1 2024, adding 164,400 shares worth $46.74 M.

According to the latest 13F filing for Q3 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 825 shares of Amgen Inc. (AMGN), valued at approximately $347,746.

As of the Q3 2026 filing, Amgen Inc. (AMGN) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.

Paul Tudor Jones's peak holding in Amgen Inc. (AMGN) was 164,400 shares, as reported at the end of Q1 2024.